DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

R Huang, PK Zhou - Signal transduction and targeted therapy, 2021 - nature.com
Genomic instability is the hallmark of various cancers with the increasing accumulation of
DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is …

HDAC inhibitors in acute myeloid leukemia

E San José-Enériz, N Gimenez-Camino, X Agirre… - Cancers, 2019 - mdpi.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled
proliferation, differentiation arrest, and accumulation of immature myeloid progenitors …

Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1, 2, 3-triazole-chalcone conjugates

EM Othman, EA Fayed, EM Husseiny, HS Abulkhair - Bioorganic Chemistry, 2022 - Elsevier
Leukemia is a life-threatening nonepithelial malignant disorder that is characterized by
uncontrolled growth of the hematopoietic cells. To date, there are still unmet needs for …

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies

A Padella, A Ghelli Luserna Di Rorà, G Marconi… - Journal of hematology & …, 2022 - Springer
The members of the Poly (ADP‐ribose) polymerase (PARP) superfamily are involved in
several biological processes and, in particular, in the DNA damage response (DDR). The …

New strategies to treat AML: novel insights into AML survival pathways and combination therapies

R Nair, A Salinas-Illarena, HM Baldauf - Leukemia, 2021 - nature.com
The effective treatment of acute myeloid leukemia (AML) is very challenging. Due to the
immense heterogeneity of this disease, treating it using a “one size fits all” approach is …

KLF5 promotes tumor progression and parp inhibitor resistance in ovarian cancer

Y Wu, S Chen, Y Shao, Y Su, Q Li, J Wu… - Advanced …, 2023 - Wiley Online Library
One major characteristic of tumor cells is the aberrant activation of epigenetic regulatory
elements, which remodel the tumor transcriptome and ultimately promote cancer …

DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy

LC de Almeida, FA Calil, JA Machado-Neto… - Cancer Genetics, 2021 - Elsevier
Cancer genome instability arises from diverse defects in DNA-repair machinery, which make
cancer cells more susceptible to DNA targeting agents. The interrelation between DNA …

Synthesis of new bioactive indolyl-1, 2, 4-triazole hybrids as dual inhibitors for EGFR/PARP-1 targeting breast and liver cancer cells

MF Youssef, MS Nafie, EE Salama, ATA Boraei… - ACS …, 2022 - ACS Publications
Cancer is the most severe disease worldwide. Every year, tens of millions of people are
diagnosed with cancer, and over half of those people will ultimately die from the disease …

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor

QX Teng, ZN Lei, JQ Wang, Y Yang, ZX Wu… - Drug Resistance …, 2024 - Elsevier
Aims The overexpression of ABC transporters on cancer cell membranes is one of the most
common causes of multidrug resistance (MDR). This study investigates the impact of ABCC1 …

[HTML][HTML] Selectively enhancing radiosensitivity of cancer cells via in situ enzyme-instructed peptide self-assembly

Y Gao, J Gao, G Mu, Y Zhang, F Huang… - … Pharmaceutica Sinica B, 2020 - Elsevier
The radiotherapy modulators used in clinic have disadvantages of high toxicity and low
selectivity. For the first time, we used the in situ enzyme-instructed self-assembly (EISA) of a …